Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masanobu Tsubaki

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2018
[MET/ERK and MET/JNK Pathway Activation Is Involved in BCR-ABL Inhibitor-resistance in Chronic Myeloid Leukemia]Masanobu Tsubaki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2017
Exploration of Molecular Targets in the Development of New Therapeutics Aimed at Overcoming Multidrug ResistanceShozo Nishida, Masanobu Tsubaki
Oncology Research|May 1, 2026
Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid LeukemiaMasanobu Tsubaki, Taira Matsuo, Rie Komori
Ear, Nose, & Throat Journal|January 26, 2008
Extramedullary plasmacytoma of the larynx: a case report from JapanTakeshi Kusunoki, Katsuhisa Ikeda, Kiyotaka Murata, et al.
Experimental Cell Research|February 21, 2024
RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathwayTomoya Takeda, Masanobu Tsubaki, Shuji Genno, et al.
Cureus|August 4, 2025
Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case SeriesTadafumi Hoshida, Kazufumi Tanabe, Masanobu Tsubaki, et al.
International Journal of Molecular Medicine|July 21, 2023
HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expressionTomoya Takeda, Masanobu Tsubaki, Shuji Genno, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 24, 2021
Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective studyDaichiro Fujiwara, Masanobu Tsubaki, Tomoya Takeda, et al.
Cureus|January 5, 2026
Bioinformatic Analysis of RNF43 and Its Co-expressors As Prognostic Biomarkers for Gastric CancerMasanobu Tsubaki, Taira Matsuo, Rie Komori, et al.
Life Sciences|September 19, 2003
A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERKShozo Nishida, Yoshiki Fujii, Shohei Yoshioka, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2018
[MET/ERK and MET/JNK Pathway Activation Is Involved in BCR-ABL Inhibitor-resistance in Chronic Myeloid Leukemia]Masanobu Tsubaki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2017
Exploration of Molecular Targets in the Development of New Therapeutics Aimed at Overcoming Multidrug ResistanceShozo Nishida, Masanobu Tsubaki
Oncology Research|May 1, 2026
Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid LeukemiaMasanobu Tsubaki, Taira Matsuo, Rie Komori
Ear, Nose, & Throat Journal|January 26, 2008
Extramedullary plasmacytoma of the larynx: a case report from JapanTakeshi Kusunoki, Katsuhisa Ikeda, Kiyotaka Murata, et al.
Experimental Cell Research|February 21, 2024
RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathwayTomoya Takeda, Masanobu Tsubaki, Shuji Genno, et al.
Cureus|August 4, 2025
Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case SeriesTadafumi Hoshida, Kazufumi Tanabe, Masanobu Tsubaki, et al.
International Journal of Molecular Medicine|July 21, 2023
HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expressionTomoya Takeda, Masanobu Tsubaki, Shuji Genno, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 24, 2021
Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective studyDaichiro Fujiwara, Masanobu Tsubaki, Tomoya Takeda, et al.
Cureus|January 5, 2026
Bioinformatic Analysis of RNF43 and Its Co-expressors As Prognostic Biomarkers for Gastric CancerMasanobu Tsubaki, Taira Matsuo, Rie Komori, et al.
Life Sciences|September 19, 2003
A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERKShozo Nishida, Yoshiki Fujii, Shohei Yoshioka, et al.
Pageof 10